Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences

4,986views

Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences

obs and gyn

obs and gyn

Anatomy of the pelvic girdle
Anatomy of the pelvic cavity
Anatomy of the breast
Arteries and veins of the pelvis
Nerves and lymphatics of the pelvis
Anatomy of the female urogenital triangle
Anatomy of the perineum
Anatomy of the female reproductive organs of the pelvis
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Female pelvis and perineum
Development of the reproductive system
Mammary gland histology
Ovary histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the female reproductive system
Puberty and Tanner staging
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Oxytocin and prolactin
Stages of labor
Breastfeeding
Precocious puberty
Delayed puberty
Klinefelter syndrome
Turner syndrome
Androgen insensitivity syndrome
5-alpha-reductase deficiency
Kallmann syndrome
Amenorrhea
Ovarian cyst
Premature ovarian failure
Polycystic ovary syndrome
Ovarian torsion
Krukenberg tumor
Ovarian sex-cord stromal tumors
Ovarian surface epithelial tumors
Ovarian germ cell tumors
Uterine fibroid
Endometriosis
Endometritis
Endometrial hyperplasia
Endometrial cancer
Choriocarcinoma
Cervical cancer
Pelvic inflammatory disease
Urethritis
Female sexual interest and arousal disorder
Orgasmic dysfunction
Genito-pelvic pain and penetration disorder
Mastitis
Fibrocystic breast changes
Intraductal papilloma
Phyllodes tumor
Paget disease of the breast
Breast cancer
Hyperemesis gravidarum
Gestational hypertension
Preeclampsia & eclampsia
Gestational diabetes
Cervical incompetence
Placenta previa
Placenta accreta
Placental abruption
Oligohydramnios
Polyhydramnios
Potter sequence
Intrauterine growth restriction
Preterm labor
Postpartum hemorrhage
Chorioamnionitis
Congenital toxoplasmosis
Congenital cytomegalovirus (NORD)
Congenital syphilis
Neonatal conjunctivitis
Neonatal herpes simplex
Congenital rubella syndrome
Neonatal sepsis
Neonatal meningitis
Miscarriage
Gestational trophoblastic disease
Ectopic pregnancy
Fetal hydantoin syndrome
Fetal alcohol syndrome
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Amenorrhea: Pathology review
Testicular and scrotal conditions: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
HIV and AIDS: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Aromatase inhibitors
Uterine stimulants and relaxants
Routine prenatal care: Clinical
Hypertensive disorders of pregnancy: Clinical
Antepartum hemorrhage: Clinical
Premature rupture of membranes: Clinical
Abnormal labor: Clinical
Vaginal versus cesarean delivery: Clinical
Postpartum hemorrhage: Clinical
Gestational trophoblastic disease: Clinical
Abdominal pain: Clinical
Amenorrhea: Clinical
Contraception: Clinical
Virilization: Clinical
Infertility: Clinical
Vulvovaginitis: Clinical
Sexually transmitted infections: Clinical
Abnormal uterine bleeding: Clinical
Ovarian cysts, cancer, and other adnexal masses: Clinical
Endometrial hyperplasia and cancer: Clinical
Cervical cancer: Clinical
Vaginal cancer: Clinical
Vulvar cancer: Clinical
Urinary incontinence: Pathology review
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Induction of labor: Clinical sciences
Pain management during labor: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Ectopic pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Anemia in pregnancy: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Asthma in pregnancy: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Breast abscess: Clinical sciences
Mastitis: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Uterine atony: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Emergency contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Reversible contraception: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Bacterial vaginosis: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Vaginal trichomoniasis: Clinical sciences
Vulvovaginal candidiasis: Clinical sciences
Approach to dysuria: Clinical sciences
Hepatitis B: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Adnexal torsion: Clinical sciences
Adenomyosis: Clinical sciences
Uterine leiomyoma: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences
Development of the fetal membranes
Development of the placenta
Development of the umbilical cord
Fetal circulation
Development of twins
Mood disorders: Pathology review
Urinary tract infections: Pathology review
Newborn management: Clinical
Mood disorders: Clinical
Perinatal infections: Clinical
Urinary tract infections: Clinical
Breast cancer: Clinical
Precocious and delayed puberty: Clinical
Congenital adrenal hyperplasia: Clinical

Decision-Making Tree

Transcript

Watch video only

Hypertension in pregnancy is not one disorder, but actually a spectrum. This spectrum begins with gestational hypertension, where a patient only has elevated blood pressure.If you add proteinuria to hypertension, then we’re talking about preeclampsia without severe features. Now, progression to preeclampsia with severe features occurs if any of the following are observed; severely elevated blood pressures; labs indicating end-organ damage like thrombocytopenia, elevated liver enzymes, or renal insufficiency; or worrisome symptoms like new onset headache, visual changes, right upper quadrant pain, or epigastric pain.

Next, HELLP syndrome occurs when a patient presents with Hemolysis, Elevated Liver enzymes, and Low Platelets. These conditions have significant maternal and fetal risks, such as stroke, pulmonary edema, renal failure, and placental abruption. Finally, if the patient had a seizure, that’s eclampsia. Most hypertensive disorders resolve by 12 weeks postpartum, and they all increase a patient's risk of developing chronic hypertension in the future.

Your first step in evaluating a pregnant patient who presents with a chief concern suggesting a hypertensive disorder in pregnancy is to perform a CABCDE assessment and conduct a primary obstetric survey.

If the patient is unstable, check for uncontrolled bleeding and control any hemorrhage, as severely elevated blood pressure may cause a placental abruption. Next, stabilize their airway, breathing, and circulation and consider intubation when appropriate. Obtain IV access and continuously monitor maternal vital signs. Perform your primary obstetric survey, which includes monitoring the fetal heart rate; possibly testing for rupture of amniotic membranes; and consider checking cervical dilation.

Alright, let’s talk about stable patients. Your first step is to obtain a focused history and physical exam. Ask about any history of hypertension, which is a big risk factor. Additional risk factors include obesity, diabetes, kidney disease, age greater than 35, nulliparity, multifetal gestation, or a history of preeclampsia.

Then, measure their blood pressure. In patients who are more than 20 weeks pregnant, a hypertensive disorder of pregnancy is suspected if they have newly elevated blood pressures of at least 140 systolic, or at least 90 diastolic, or both, on two separate occasions more than 4 hours apart.

Okay, once you suspect a hypertensive disorder in pregnancy, it’s time to check labs. Obtain a CBC, CMP, LDH, and a urine protein-to-creatinine ratio; and possibly a 24-hour urine collection to measure total protein.

Alright, if your patient has normal labs and has no symptoms of preeclampsia, you can confirm the diagnosis of gestational hypertension. Antepartum management includes monitoring blood pressure and starting an antihypertensive medication like labetalol or nifedipine, if blood pressure is persistently above 140 systolic, 90 diastolic, or both. Antenatal fetal surveillance with non-stress tests and serial ultrasounds to assess fetal growth are recommended.

Additionally, monitor for disease progression by assessing blood pressure, serial labs, and asking about symptoms of preeclampsia with severe features. If maternal and fetal status are reassuring, you can wait until 37 weeks to deliver the fetus. Vaginal delivery is appropriate unless there are contraindications like fetal malpresentation or prior classical C-section.

While intrapartum, closely monitor maternal and fetal status for evidence of severe features, as they require additional interventions. In the postpartum period, schedule a short-interval blood pressure check, and discuss return precautions if they experience signs and symptoms of preeclampsia with severe features. Half of all patients with gestational hypertension will eventually develop preeclampsia, with those diagnosed prior to 32 weeks at highest risk. This is why close monitoring for disease progression is so important!

Now let’s talk about patients who have proteinuria. Patients with new-onset hypertension after 20 weeks gestation plus proteinuria meet the diagnosis of preeclampsia. Proteinuria is defined as a urine protein-to-creatinine ratio greater than or equal to 0.3, or a 24-hour urine collection with at least 300 mg of protein.

Once you’ve diagnosed preeclampsia, next assess for severe features. These include blood pressures of at least 160 systolic or 110 diastolic on two occasions at least 4 hours apart; laboratory abnormalities like thrombocytopenia with a platelet count of less than 100,000, renal insufficiency with a creatinine greater than 1.1, elevated liver function tests greater than two times the upper limit of normal; and signs or symptoms such as pulmonary edema, new-onset headache that does not improve with medication, visual symptoms like spots or blurry vision, severe, persistent right upper quadrant abdominal pain, or epigastric pain.

Here’s a clinical pearl! While blood pressure should be measured on two separate occasions at least 4 hours apart, in an acute setting with severely elevated blood pressures the diagnosis can be made within minutes to allow for timely intervention!

Patients with preeclampsia without severe features should be monitored closely in the outpatient setting. Consider starting an antihypertensive if blood pressure is persistently above 140 systolic, 90 diastolic, or both. Initiate antenatal fetal surveillance with non-stress tests and serial ultrasounds, and monitor for severe features with serial labs and symptomatology. As long as they remain asymptomatic for severe features with reassuring blood pressure, fetal status, and labs, vaginal delivery at 37 weeks is recommended.

Sources

  1. "ACOG committee opinion no. 828: Indications for outpatient antenatal fetal surveillance" Obstet Gynecol (2021)
  2. "ACOG practice bulletin no. 222: Gestational hypertension and preeclampsia" Obstet Gynecol (2020)
  3. "Clinical practice update: Biomarker Prediction of Preeclampsia with Severe Features" Obstet Gynecol (2024)